🔥 non-medical 🌎 planetary health is critical Check out this video by naturalists about sustainable tourism and ocean protection on the Azores. Scientist-led, EU-funded 🇪🇺 Happy to have joined this year. Check it out. support them if you visit the Azores. www.euronews.com/green/2025/0...

🔥 Looking for automated segmentation of liver histopathology? Don‘t look further. Hotspot Model got you covered. Happy to have contributed. Great work @aleger87.bsky.social and team! rdcu.be/ew7qh

🔥 Publication alert from us! 🧬 Distinct molecular profiles of AMR and TCMR after #liver #transplant 📈 AMR associates w/ high rate of graft #cirrhosis 🧪 IFN mediates TCMR, TNF mediates AMR as in other SOT doi.org/10.1016/j.jh... #openaccess @jhepatology.bsky.social #liversky @easlnews.bsky.social

🔥 Publication alert from our group! 🧬 Distinct molecular profiles of AMR and TCMR after #liver #transplant 📈 AMR associates w/ high rates of graft #cirrhosis 🧪 IFN mediates TCMR and TNF mediates AMR as in other solid organs #openaccess @jhepatology.bsky.social #liversky @easlnews.bsky.social

Thank you for sharing! It was a pleasure working on this, together with @twittlabs.bsky.social , @jnkt.bsky.social and many others...

Whom to treat in #AIH #cirrhosis with decompensation? 💊 Steroids if: 🧠 encephalopathy equal or less than grade 2 📈 MELD-Na 28 or below 🚒If patients with AIH do not meet this criteria #transplant might be the better option. #liversky @easlnews.bsky.social authors.elsevier.com/c/1l6Pu5UiFS...

🆕CPG in press❕ EASL Clinical Practice Guidelines on extrahepatic abdominal surgery in patients with cirrhosis and advanced chronic liver disease Find it here👉https://bit.ly/3GM9EEB #LiverSky @easlnews.bsky.social

New @thelancet.bsky.social - Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial www.thelancet.com/journals/lan... #Liversky #Oncsky #Medsky #EASL2025

Can’t wait for #EASL2025! @easlnews.bsky.social Join Colm O’Rourke and me, on Friday for a session we’ve designed and are thrilled to chair: “Do’s and Don’ts in Liver Transcriptomics” Arnold Room | 3–4PM Come for insights, tips & tricks from Neil Henderson, Johan Ankarklev, & Simon Cockell!

🆕CPG❕ EASL Clinical Practice Guidelines on TIPS ✅Addresses all aspects of #TIPS in patients with #cirrhosis Full text here: bit.ly/4hZuMUK #LiverSky @easlnews.bsky.social

🤔How is #hepD treated? Why is this relevant for #hepB patients? 🇩🇪🗺️ 🎞️Watch insights from #internists 🥼#HelenieKefalakes #LisaSandmann in our fresh release youtu.be/d7dV2G6tMXA #hepatitisawareness📺with experts answering key #HBV #HDV questions #MHH #B_Aware #D-SOLVE #LiverHealth #LiverSky #HepSky

✮ Kather Lab is hiring PostDocs & Software Engineers! ☞ Strong Python & PyTorch skills, GitHub experience, and interest in LLMs & computational pathology required. 

 Apply here╰( ͡° ͜ʖ ͡° )つ──☆*・ﾟ: bit.ly/42nY62u

Happy to share our latest paper in @ai.nejm.org, led by Isabella Wiest: "Deidentifying Medical Documents with Local, Privacy-Preserving Large Language Models: The LLM-Anonymizer" ai.nejm.org/doi/full/10.... You can use our open source tool with local LLMs to robustly de-identify medical documents.

Spicy! Adding lasix to the management of hepatorenal syndrome might be ok if you bump the MAP with pressors @juancarlosqvelez.bsky.social doi.org/10.1016/j.ek... #nephsky #liversky

Find the latest evidence on #autoimmune #liver diseases (in German, but #AI will help to translate) in which we summarize the latest evidence, finally on the highest level achievable for guidelines. This highlights the progress in the #AILD field in the last years. www.dgvs.de/leitlinien/l...

Fresh from #Hepatology, cross-sectional multicenter study on Quality of Life in #AIH. 👍 882 patients, 178 controls across Europe #ERN 👎 QoL impaired mainly by physical complaints 📈 QoL correlated w/ depression/anxiety 💊 remission associated w/ improved symptoms doi.org/10.1097/HEP.0000000000001271

In today's #readoftheweek📚 learn about the ALNE model and how it generates quantitative and accurate differential diagnosis between cases with AIH or PBC. Read here this JHEP Reports article: www.jhep-reports.eu/article/S258... @jhepatology.bsky.social #LiverSky

Happy to have contributed to this project led by @aleger87.bsky.social 🤖 ML-based detection of AIH and PBC from H&E stained slides 💥 solid performance with heterogenous staining/scanning 😳 no annotation needed More to come and looking forward to it! @jnkt.bsky.social #liversky

🔥 off the press. Multicenter study using proteomic signatures to identify biomarker candidates in acute liver failure led by Pavel Strnad from Aachen. 🏨 disriminate APAP from non-APAP 📉 predict transplant-free survival from 🩸 🧮 outperform MELD and AFLSG-PI Great work 👏 doi.org/10.1016/j.jh...

The autoimmune hepatitis field is quite unique in the way clinicians and researchers on AIH are connected personally worldwide. Optimal starting point for generalizable prediction algorithms ...

Starting on Bluesky with our summary about most pressing issues in #AIH 🤖 Employing AI for research and patient information 🧬 Unveil pathogenesis by using single cell techniques 🧪 new biomarkers, validate candidates 📊 New clinical trials, harmonize outcome sets www.jhep-reports.eu/article/S258...

Two papers in Nature Climate Change suggest that exceeding 1.5 °C in 2024 may indicate that we have entered a multi-decadal period of 1.5 °C average global warming. https://go.nature.com/4hR9GYO https://go.nature.com/3WVdJM1 🧪

Thermal ablation vs surgical resection of small colorectal liver metastases (COLLISION trial) “The assumption that thermal ablation should be reserved for unresectable colorectal liver mets requires re-evaluation” www.thelancet.com/journals/lan... #GastroSky #OncSky #MedSky @oncoalert.bsky.social